Future prospective studies are therefore needed to investigate the pattern of methylation and miRNA expression changes in GNPDA1 and SLC25A26 in a cohort population with breast cancer and incorporate comprehensive genetic screening to further elucidate the relationship between hereditary mutations, family history, and molecular alterations. Here, SLC25A26 is linked to breast carcinoma.